Protalix BioTherapeutics Reports Second Quarter 2016 Financial Results
Go back to Protalix BioTherapeutics Reports Second Quarter 2016 Financial Results| PROTALIX BIOTHERAPEUTICS, INC. COMMON STOCK (NYSE: PLX) | Delayed: 2.16 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.16 | 52 Week High | $1.11 | |||
| Open | $2.16 | 52 Week Low | $0.41 | |||
| Day High | $2.16 | P/E | N/A | |||
| Day Low | $2.16 | EPS | $-0.29 | |||
| Volume | 5,326 | |||||
| PROTALIX BIOTHERAPEUTICS, INC. COMMON STOCK (NYSE: PLX) | Delayed: 2.16 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.16 | 52 Week High | $1.11 | |||
| Open | $2.16 | 52 Week Low | $0.41 | |||
| Day High | $2.16 | P/E | N/A | |||
| Day Low | $2.16 | EPS | $-0.29 | |||
| Volume | 5,326 | |||||

